ERGi-USU
NSC-139021 (ERGi-USU) is a selective small molecule inhibitor targeting Rio2 kinase (RIOK2), leading to the suppression of the oncogenic ERG transcription factor. This compound is utilized in research to investigate ERG-driven cancers, such as prostate leukemia, in both cellular and animal models.
Product Specifications
CAS Number
1147-56-4
Product Name Alternative
NSC139021
Purity
>98%
Bioactivity
Highly selective ERG inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to at least 10 mg/ml)
Smiles
Oc1ccc2ccccc2c1N=Nc1nccs1
Molecular Formula
C13H9N3OS
Molecular Weight
255.30
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
1- (2-Thiazolylazo) -2-naphthol
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1144149-01 0.02 mg (E-Coli)
Recombinant Magnetococcus sp. Ribosome-binding factor A (rbfA)
Sign In for Pricing
View Details MBS1144149-02 0.1 mg (E-Coli)
Recombinant Magnetococcus sp. Ribosome-binding factor A (rbfA)
Sign In for Pricing
View Details MBS1144149-03 0.02 mg (Yeast)
Recombinant Magnetococcus sp. Ribosome-binding factor A (rbfA)
Sign In for Pricing
View Details MBS1144149-04 0.1 mg (Yeast)
Recombinant Magnetococcus sp. Ribosome-binding factor A (rbfA)
Sign In for Pricing
View Details MBS1144149-05 0.02 mg (Baculovirus)
Recombinant Magnetococcus sp. Ribosome-binding factor A (rbfA)
Sign In for Pricing
View Details MBS1144149-06 0.02 mg (Mammalian-Cell)
Recombinant Magnetococcus sp. Ribosome-binding factor A (rbfA)
Sign In for Pricing
View Details